247 related articles for article (PubMed ID: 35057816)
1. The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China.
Yang GJ; Shang LY; Zhou XN; Lee TE; Bi B; White M; Smith TA; Penny MA
BMC Med; 2022 Jan; 20(1):17. PubMed ID: 35057816
[TBL] [Abstract][Full Text] [Related]
2. Hypnozoite dynamics for Plasmodium vivax malaria: The epidemiological effects of radical cure.
Mehra S; Stadler E; Khoury D; McCaw JM; Flegg JA
J Theor Biol; 2022 Mar; 537():111014. PubMed ID: 35016895
[TBL] [Abstract][Full Text] [Related]
3. Relapse.
White NJ; Imwong M
Adv Parasitol; 2012; 80():113-50. PubMed ID: 23199487
[TBL] [Abstract][Full Text] [Related]
4. From Plasmodium vivax outbreak to elimination: lessons learnt from a retrospective analysis of data from Guantang.
Yang GJ; Liu Y; Shang LY; Zhang HW; Zhou XN; Penny MA; Smith TA
Malar J; 2020 Nov; 19(1):427. PubMed ID: 33228679
[TBL] [Abstract][Full Text] [Related]
5. Optimal Interruption of P. vivax Malaria Transmission Using Mass Drug Administration.
Anwar MN; Hickson RI; Mehra S; Price DJ; McCaw JM; Flegg MB; Flegg JA
Bull Math Biol; 2023 Apr; 85(6):43. PubMed ID: 37076740
[TBL] [Abstract][Full Text] [Related]
6.
Schäfer C; Zanghi G; Vaughan AM; Kappe SHI
Annu Rev Microbiol; 2021 Oct; 75():87-106. PubMed ID: 34196569
[No Abstract] [Full Text] [Related]
7. Determinants of relapse periodicity in Plasmodium vivax malaria.
White NJ
Malar J; 2011 Oct; 10():297. PubMed ID: 21989376
[TBL] [Abstract][Full Text] [Related]
8. Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model.
Robinson LJ; Wampfler R; Betuela I; Karl S; White MT; Li Wai Suen CS; Hofmann NE; Kinboro B; Waltmann A; Brewster J; Lorry L; Tarongka N; Samol L; Silkey M; Bassat Q; Siba PM; Schofield L; Felger I; Mueller I
PLoS Med; 2015 Oct; 12(10):e1001891. PubMed ID: 26505753
[TBL] [Abstract][Full Text] [Related]
9. Elimination of malaria due to Plasmodium vivax in central part of the People's Republic of China: analysis and prediction based on modelling.
Chen Z; Shi L; Zhou XN; Xia ZG; Bergquist R; Jiang QW
Geospat Health; 2014 Nov; 9(1):169-77. PubMed ID: 25545934
[TBL] [Abstract][Full Text] [Related]
10. [Role of primaquine in malaria control and elimination in French-speaking Africa].
Briolant S; Pradines B; Basco LK
Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
[TBL] [Abstract][Full Text] [Related]
11. Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax.
Campo B; Vandal O; Wesche DL; Burrows JN
Pathog Glob Health; 2015 May; 109(3):107-22. PubMed ID: 25891812
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium vivax Relapse Rates in Allied Soldiers during the Second World War: Importance of Hypnozoite Burden.
Shanks GD
Am J Trop Med Hyg; 2022 Dec; 107(6):1173-1177. PubMed ID: 36343595
[TBL] [Abstract][Full Text] [Related]
13. Quantifying effect of geographic location on epidemiology of Plasmodium vivax malaria.
Lover AA; Coker RJ
Emerg Infect Dis; 2013 Jul; 19(7):1058-65. PubMed ID: 23763820
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium vivax malaria: a re-emerging threat for temperate climate zones?
Petersen E; Severini C; Picot S
Travel Med Infect Dis; 2013; 11(1):51-9. PubMed ID: 23498971
[TBL] [Abstract][Full Text] [Related]
15. Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission.
White MT; Karl S; Battle KE; Hay SI; Mueller I; Ghani AC
Elife; 2014 Nov; 3():. PubMed ID: 25406065
[TBL] [Abstract][Full Text] [Related]
16. Activation of the hypnozoite: a part of Plasmodium vivax life cycle and survival.
Hulden L; Hulden L
Malar J; 2011 Apr; 10():90. PubMed ID: 21496287
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of Plasmodium vivax populations in border areas of the Greater Mekong sub-region during malaria elimination.
Li Y; Hu Y; Zhao Y; Wang Q; Ngassa Mbenda HG; Kittichai V; Lawpoolsri S; Sattabongkot J; Menezes L; Liu X; Cui L; Cao Y
Malar J; 2020 Apr; 19(1):145. PubMed ID: 32268906
[TBL] [Abstract][Full Text] [Related]
18. A model for malaria treatment evaluation in the presence of multiple species.
Walker CR; Hickson RI; Chang E; Ngor P; Sovannaroth S; Simpson JA; Price DJ; McCaw JM; Price RN; Flegg JA; Devine A
Epidemics; 2023 Sep; 44():100687. PubMed ID: 37348379
[TBL] [Abstract][Full Text] [Related]
19. Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses.
White M; Amino R; Mueller I
Trends Parasitol; 2017 Apr; 33(4):260-263. PubMed ID: 28077251
[TBL] [Abstract][Full Text] [Related]
20. Insights into the elimination of vivax malaria in China.
Huang F; Zhang L; Xia ZG
Infect Dis Poverty; 2023 Mar; 12(1):23. PubMed ID: 36941701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
